 Antibiotic-associated hypoprothrombinemia review prospective studies Many antimicrobial agents hypoprothrombinemia precise mechanisms unknown alteration vitamin status utilization mechanisms direct inhibition biosynthesis vitamin K-dependent clotting factors N-methylthiotetrazole NMTT moiety certain antimicrobial agents eradication vitamin K-producing intestinal microflora patients reduced oral intake vitamin English-language review prospective studies serial prothrombin times adult patients incidence hypoprothrombinemia NMTT-containing regimens non-NMTT-containing regimens Detailed evaluation studies certain risk factors malnutrition hepatic renal dysfunction age severity illness major determinants hypoprothrombinemia hypothesis NMTT side chain responsible hypoprothrombinemia patients high risk coagulopathy serious consideration use prophylactic vitamin cases